Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

This study has been completed.
Information provided by (Responsible Party):
Xue Qing Yu, Sun Yat-sen University Identifier:
First received: July 22, 2008
Last updated: May 18, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)